Schneider et al., 1989 - Google Patents
Determination of the new monoamine oxidase inhibitor brofaromine and its major metabolite in biological material by gas chromatography with electron-capture …Schneider et al., 1989
- Document ID
- 17144251120650750566
- Author
- Schneider W
- Keller B
- Degen P
- Publication year
- Publication venue
- Journal of Chromatography B: Biomedical Sciences and Applications
External Links
Snippet
A sensitive gas chromatographic assay for the simultaneous determination of brofaromine [4- (7-bromo-5-methoxy-2-benzofuranyl) piperidine hydrochloride], a new monoamine oxidase- A inhibitor, and its major metabolite was developed and validated. After addition of 4-(5 …
- 239000002207 metabolite 0 title abstract description 32
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in positions 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in positions 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7741482B2 (en) | Reference standard for characterization of rosuvastatin | |
| US7294735B2 (en) | Purification of cinacalcet | |
| De Silva et al. | Determination medazepam (Nobrium), diazepam (Valium), and their major biotransformation products in blood and urine by electron capture gas-liquid chromatography | |
| Pommier et al. | Quantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry | |
| Lin et al. | Characterization of metabolites of clozapine N-oxide in the rat by micro-column high performance liquid chromatography/mass spectrometry with electrospray interface | |
| Schneider et al. | Determination of the new monoamine oxidase inhibitor brofaromine and its major metabolite in biological material by gas chromatography with electron-capture detection | |
| Appolonova et al. | Liquid chromatography—electrospray ionization ion trap mass spectrometry for analysis of mesocarb and its metabolites in human urine | |
| Belal et al. | Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative | |
| Zobel et al. | LC–MS/MS procedure for the simultaneous determination of N-acetyl-S-(1-naphthyl) cysteine and N-acetyl-S-(2-napthyl) cysteine in human urine | |
| Paci et al. | Quantitative high-performance liquid chromatographic determination of acrolein in plasma after derivatization with Luminarin® 3 | |
| Freitag et al. | High-performance liquid chromatographic method for resolving the enantiomers of mexiletine and two major metabolites isolated from microbial fermentation media | |
| Hale Jr et al. | Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration | |
| CA2680604C (en) | Triol form of rosuvastatin | |
| Glushkova et al. | Synthesis and Pharmacokinetics of 2-(4-amino-3, 5-dichlorophenyl)-2-(alkylamino) ethanols-Structural Isomers of β2 Agonists Clenproperol and Clenpenterol | |
| Andersen et al. | Determination of ragaglitazar, a novel dual acting peroxisome proliferator-activated receptor (PPAR) α and-γ agonist, in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry | |
| Inoue et al. | Sensitive determination of pipecolic acid in serum by high-performance liquid chromatography using 4-(5, 6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labelling reagent | |
| Kender et al. | Imipramine hydrochloride | |
| Vandenabeele-Trambouze et al. | Reactivity of 3 isopropenyl-α, α-dimethyl-benzylisocyanate with amines, phenols, thiols and oximes in diluted aqueous–organic media: The water-promoted effect | |
| Thongnopnua et al. | Quantitative determination of 2-methoxy-1, 4-naphthoquinone in plasma by high-performance liquid chromatography | |
| Himber et al. | Determination of Falintolol, A New Aliphatic β-Adrenergic Antagonist, in Whole Blood by Gas Chromatography with Electron-Capture Detection: Geometric Isomers Resolution | |
| CY1377A (en) | Quantitative determination of encainide | |
| Grushevskaya et al. | Developing analytical methods for afobazole in injection forms |